- Awards
- 25
- Value outside frameworks
- -
- Framework places
- 4
- Shared awards
- 16
Values exclude VAT where the notices give it, and only values in pounds are added up. A framework place carries the framework's whole ceiling, shared with the other suppliers on it, so framework places are counted rather than added up; so are awards made to several suppliers together.
Awards
| Procurement | Buyer | Value | Date |
| LSL/MED/0228 Supply of Pfizer Pharmaceutical Products framework |
Leidos Supply, Limited |
£4,500,000 |
7 Oct 2026 |
| NHS National Framework for Tafamidis framework |
NHS England |
£62,393,000 |
29 Sep 2026 |
| NHS National Framework for Generics Housekeeping framework |
NHS England |
£21,562,716 |
10 Nov 2025 |
| NHS National Framework for Transition products (Axitinib and Eltrombopag) framework |
NHS England |
£52,385,000 |
16 Jul 2025 |
| Terms and Conditions for the Supply of Centrally Procured Vaccines |
Business Energy and Industrial Strategy |
- |
7 Jun 2021 |
| Deed Of Amendment |
Business Energy and Industrial Strategy |
- |
29 Mar 2021 |
| NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche |
NHS England |
- |
11 Feb 2021 |
| Terms and Conditions for the Supply of Centrally Procured Vaccines - SARS-CoV-2 VACCINE SUPPLY AGREEMENT |
Business Energy and Industrial Strategy |
- |
12 Oct 2020 |
| Contract for the supply of stockpiled medicines shared |
Department of Health and Social Care |
£5,680,770 |
17 Jun 2020 |
| NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared |
NHS England |
£191,062,951 |
17 Jun 2020 |
| NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A shared |
NHS England |
£334,400,000 |
3 Jun 2020 |
| Contracts for the supply of Azithromycin & Dexamethasone products pt2 shared |
Department of Health and Social Care |
£2,108,686 |
11 May 2020 |
| NHS Framework Agreement - North of England - Tranche B shared |
NHS England |
£205,535,556 |
13 Feb 2020 |
| NHS Midlands and East Branded Medicines - Tranche A shared |
NHS England |
£418,787,000 |
15 Jan 2020 |
| NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared |
NHS England |
£188,004,961 |
1 Aug 2019 |
| NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared |
NHS England |
£251,930,337 |
5 Jul 2019 |
| NHS Framework Agreement for Branded Medicines - National shared |
NHS England |
£1,351,341,890 |
1 May 2019 |
| NHS Framework agreement for Branded Medicines - North of England - Tranche A shared |
NHS England |
£204,551,038 |
18 Feb 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England - Midlands and East Branded Medicines - Tranche B shared |
NHS England |
£295,035,882 |
17 Jan 2019 |
| NHS England Framework Agreement: South of England (Tranche B) shared |
NHS England |
£501,400,000 |
14 Sep 2018 |
| Contract for the supply of meningococcal ACWY vaccine |
Department Of Health |
- |
6 Sep 2018 |
| NHS England Framework Agreement - London - Tranche A shared |
NHS England |
£211,435,404 |
15 Aug 2018 |
Top buyers
By number of awards. Value is the total of awards made to this supplier alone outside frameworks, excluding VAT where the notices give it.